# Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer

> **NCT07643012** · NA · RECRUITING · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 30 (estimated)

## Conditions studied

- Endometrial Cancer

## Interventions

- **RADIATION:** MR-guided adaptive pelvic intensity-modulated radiation therapy (IMRT)

## Key facts

- **NCT ID:** NCT07643012
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-09
- **Primary completion:** 2029-06
- **Final completion:** 2029-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07643012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07643012, "Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07643012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*